Analysts Set Cigna Co. (NYSE:CI) PT at $276.63

Cigna Co. (NYSE:CIGet Rating) has been given a consensus recommendation of “Buy” by the twenty-six ratings firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation, thirteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $278.96.

A number of research firms have issued reports on CI. SVB Leerink increased their target price on shares of Cigna from $224.00 to $245.00 and gave the stock a “market perform” rating in a report on Tuesday, February 22nd. Morgan Stanley reduced their target price on shares of Cigna from $238.00 to $235.00 and set an “equal weight” rating on the stock in a report on Thursday, February 10th. Wells Fargo & Company increased their target price on shares of Cigna from $278.00 to $306.00 in a report on Monday, May 9th. Truist Financial increased their target price on shares of Cigna from $290.00 to $310.00 in a report on Monday, May 9th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Cigna from a “buy” rating to a “hold” rating and dropped their price objective for the company from $271.00 to $236.00 in a research report on Friday, February 4th.

In other Cigna news, EVP Everett Neville sold 268 shares of the firm’s stock in a transaction on Monday, February 28th. The shares were sold at an average price of $228.70, for a total transaction of $61,291.60. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO David Cordani sold 10,069 shares of the firm’s stock in a transaction on Monday, February 28th. The stock was sold at an average price of $228.70, for a total transaction of $2,302,780.30. The disclosure for this sale can be found here. Insiders have sold a total of 91,836 shares of company stock worth $23,795,261 over the last three months. 0.80% of the stock is currently owned by insiders.

Hedge funds have recently added to or reduced their stakes in the company. Country Trust Bank lifted its stake in shares of Cigna by 116.7% in the 1st quarter. Country Trust Bank now owns 104 shares of the health services provider’s stock worth $25,000 after acquiring an additional 56 shares during the period. Missouri Trust & Investment Co acquired a new stake in shares of Cigna in the 4th quarter worth $28,000. Wagner Wealth Management LLC lifted its stake in shares of Cigna by 144.4% in the 4th quarter. Wagner Wealth Management LLC now owns 132 shares of the health services provider’s stock worth $30,000 after acquiring an additional 78 shares during the period. Exane Derivatives lifted its stake in shares of Cigna by 6,200.0% in the first quarter. Exane Derivatives now owns 126 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 124 shares during the period. Finally, Lloyd Advisory Services LLC. acquired a new stake in shares of Cigna in the first quarter valued at about $30,000. Institutional investors own 88.57% of the company’s stock.

Shares of CI stock traded up $4.09 during trading hours on Friday, hitting $270.58. The company had a trading volume of 28,389 shares, compared to its average volume of 1,419,279. The company’s fifty day moving average is $249.57 and its 200 day moving average is $233.01. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.70 and a quick ratio of 0.70. Cigna has a fifty-two week low of $191.74 and a fifty-two week high of $269.97. The stock has a market capitalization of $85.85 billion, a PE ratio of 16.63, a price-to-earnings-growth ratio of 1.03 and a beta of 0.78.

Cigna (NYSE:CIGet Rating) last issued its quarterly earnings data on Friday, May 6th. The health services provider reported $6.01 EPS for the quarter, topping the consensus estimate of $5.13 by $0.88. The firm had revenue of $44.01 billion for the quarter, compared to analyst estimates of $43.48 billion. Cigna had a net margin of 3.04% and a return on equity of 15.31%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the business posted $4.73 EPS. Equities analysts forecast that Cigna will post 22.66 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 23rd. Investors of record on Wednesday, June 8th will be given a $1.12 dividend. This represents a $4.48 dividend on an annualized basis and a dividend yield of 1.66%. The ex-dividend date of this dividend is Tuesday, June 7th. Cigna’s dividend payout ratio (DPR) is 27.79%.

Cigna Company Profile (Get Rating)

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

See Also

Analyst Recommendations for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.